Viracta Therapeutics, Inc.Viracta Therapeutics, Inc.Viracta Therapeutics, Inc.

Viracta Therapeutics, Inc.

No trades
See on Supercharts

Price target

7.000.00 0.00%
The 4 analysts offering 1 year price forecasts for VIRX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to VIRX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

VIRX EPS for the last quarter is −0.35 USD despite the estimation of −0.31 USD. In the next quarter EPS is expected to reach −0.35 USD. Track more of Viracta Therapeutics, Inc. financials and stay on top of what is up with the company.
According to analysts, VIRX price target is 7.00 USD with a max estimate of 13.00 USD and a min estimate of 4.00 USD. Check if this forecast comes true in a year, meanwhile watch Viracta Therapeutics, Inc. stock price chart and keep track of the current situation with VIRX news and stock market news.